BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 16368729)

  • 1. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a Southern Hemisphere region.
    Gibson A; Stamp LK; Chapman PT; O'Donnell JL
    Rheumatology (Oxford); 2006 May; 45(5):624-8. PubMed ID: 16368729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales.
    Ormerod AS; Cook MC
    Intern Med J; 2008 Nov; 38(11):816-23. PubMed ID: 18771432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of Wegener's granulomatosis in northern Norway.
    Koldingsnes W; Nossent H
    Arthritis Rheum; 2000 Nov; 43(11):2481-7. PubMed ID: 11083271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden.
    Mohammad AJ; Jacobsson LT; Mahr AD; Sturfelt G; Segelmark M
    Rheumatology (Oxford); 2007 Aug; 46(8):1329-37. PubMed ID: 17553910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Wegener granulomatosis and microscopic polyangiitis. Diagnostic and clinical results in 54 patients with long-term follow-up].
    Bolley R; Mistry-Burchardi N; Samtleben W
    Dtsch Med Wochenschr; 2000 Dec; 125(50):1519-25. PubMed ID: 11190761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis.
    Chen M; Yu F; Wang SX; Zou WZ; Zhang Y; Zhao MH; Wang HY
    Nephrol Dial Transplant; 2007 Jan; 22(1):139-45. PubMed ID: 16980322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions.
    Gonzalez-Gay MA; Garcia-Porrua C; Guerrero J; Rodriguez-Ledo P; Llorca J
    Arthritis Rheum; 2003 Jun; 49(3):388-93. PubMed ID: 12794795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil cytoplasmic autoantibody in the absence of Wegener's granulomatosis or microscopic polyangiitis: implications for the surgical pathologist.
    Gal AA; Velasquez A
    Mod Pathol; 2002 Mar; 15(3):197-204. PubMed ID: 11904336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.
    Liu LJ; Chen M; Yu F; Zhao MH; Wang HY
    Nephrology (Carlton); 2008 Oct; 13(7):629-35. PubMed ID: 18775059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation between Wegener's granulomatosis and microscopic polyangiitis by an artificial neural network and by traditional methods.
    Linder R; Orth I; Hagen EC; van der Woude FJ; Schmitt WH
    J Rheumatol; 2011 Jun; 38(6):1039-47. PubMed ID: 21324966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary systemic vasculitis: clinical features and mortality.
    Lane SE; Watts RA; Shepstone L; Scott DG
    QJM; 2005 Feb; 98(2):97-111. PubMed ID: 15655098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa.
    Mohammad AJ; Jacobsson LT; Westman KW; Sturfelt G; Segelmark M
    Rheumatology (Oxford); 2009 Dec; 48(12):1560-5. PubMed ID: 19797309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antineutrophil cytoplasmic antibodies (ANCA): clinico-pathologic correlations iin a series of 82 cases].
    Calvo Romero JM; Romero Requena J; Arévalo Lorido JC; Ramos Salado JL; Doblaré Castellano E; Vargas Pérez ML; Bureo Dacal P; Pérez Miranda M
    An Med Interna; 2002 Jan; 19(1):7-10. PubMed ID: 11989089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Wegener's granulomatosis and microscopic polyangiitis].
    Pagnoux C
    Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation?
    Gatenby PA; Lucas RM; Engelsen O; Ponsonby AL; Clements M
    Arthritis Rheum; 2009 Oct; 61(10):1417-24. PubMed ID: 19790114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ANCA-associated forms of vasculitis].
    Helmchen U; Kneissler U; Prall F
    Verh Dtsch Ges Pathol; 1996; 80():38-45. PubMed ID: 9065053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy is increased in ANCA-associated vasculitis.
    Pankhurst T; Savage CO; Gordon C; Harper L
    Rheumatology (Oxford); 2004 Dec; 43(12):1532-5. PubMed ID: 15316126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of anti-neutrophil cytoplasm antibodies detected by a standardized indirect immunofluorescence assay.
    Davenport A; Lock RJ; Wallington TB; Feest TG
    Q J Med; 1994 May; 87(5):291-9. PubMed ID: 7938409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological features of Wegener's granulomatosis and microscopic polyangiitis: two diseases or one 'anti-neutrophil cytoplasm antibodies-associated vasculitis' entity?
    Mahr AD
    APMIS Suppl; 2009 Jun; (127):41-7. PubMed ID: 19515139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wegener's granulomatosis: epidemiological and clinical features in a South Australian study.
    Hissaria P; Cai FZ; Ahern M; Smith M; Gillis D; Roberts-Thomson P
    Intern Med J; 2008 Oct; 38(10):776-80. PubMed ID: 19143878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.